171 – 180 of 2019
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
One year weekly size-resolved air sampling of SARS-CoV-2 in hospital corridors and relations to the indoor environment
- Contribution to journal › Article
-
Mark
Non-betahemolytic streptococcal bacteremia, cardiac implantable electronic device, endocarditis, extraction, and outcome; a population-based retrospective cohort study
- Contribution to journal › Article
-
Mark
Hepcidin, in contrast to heparin binding protein, does not portend acute kidney injury in patients with community acquired septic shock
- Contribution to journal › Article
-
Mark
Campylobacter infections with and without bacteraemia- a comparative retrospective population-based study
- Contribution to journal › Article
-
Mark
Infectivity of exhaled SARS-CoV-2 aerosols is sufficient to transmit covid-19 within minutes
(2024) Aerosols and Microbiology
- Contribution to conference › Abstract
-
Mark
Airborne SARS-CoV-2 in healthcare settings : when, where and how to prevent it?
(2024) Aerosols and Microbiology
- Contribution to conference › Abstract
-
Mark
Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia – a retrospective cohort study on the role of bacteriuria
- Contribution to journal › Article
-
Mark
Multimodal Mass Spectrometry Identifies a Conserved Protective Epitope in S. pyogenes Streptolysin O
- Contribution to journal › Article
-
Mark
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
- Contribution to journal › Article
-
Mark
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
- Contribution to journal › Scientific review
